Regulation of house dust mite responses by intranasally administered peptide: transient activation of CD4+ T cells precedes the development of tolerance in vivo - PubMed (original) (raw)
Regulation of house dust mite responses by intranasally administered peptide: transient activation of CD4+ T cells precedes the development of tolerance in vivo
G F Hoyne et al. Int Immunol. 1996 Mar.
Abstract
We have previously demonstrated that intranasal (i.n.) administration of an immunodominant peptide (p1-111-139) derived from the house dust mite (HDM) allergen Der p 1 inhibits antigen-specific CD4+ T cell responses in H-2b mice. Here we report that i.n. peptide induced a rapid but transient activation of MHC class II restricted CD4+ T cells that peaked 4 days after peptide treatment and was of similar magnitude to that induced by parenteral immunization with antigen in adjuvant. During the early phase of the response lymph node and splenic T cells secreted a range of lymphokines when re-stimulated in vitro with p1 111-139; however, by day 14 IL-2 and IFN-gamma secretion by T cells were down-regulated. Mice deficient in CD8+ T cells became tolerant by i.n. treatment with peptide, suggesting that CD8+ T cells are not involved in down-regulating the CD4+ T cell response. Rechallenging mice with a single dose of p1 111-139 21 days after the initial treatment elicited a further transient T cell response, which was subsequently down-regulated over time. Although the i.n. peptide induced a strong transient CD4+ T cell response, only low levels of peptide-specific antibodies were detected either after the initial or subsequent i.n. exposures to p1 111-139. Our findings address the mechanisms underlying peripheral T cell tolerance following i.n. administration of a high dose of immunogenic peptide and have implications for understanding the consequences of peptide immunothearapy.
Similar articles
- Prediction of murine MHC class I epitopes in a major house dust mite allergen and induction of T1-type CD8+ T cell responses.
Harris SJ, Roth JF, Savage N, Woodrow SA, Hemingway IK, Hoyne GF, Lamb JR, Layton GT. Harris SJ, et al. Int Immunol. 1997 Feb;9(2):273-80. doi: 10.1093/intimm/9.2.273. Int Immunol. 1997. PMID: 9040009 - Linked suppression in peripheral T cell tolerance to the house dust mite derived allergen Der p 1.
Hoyne GF, Dallman MJ, Lamb JR. Hoyne GF, et al. Int Arch Allergy Immunol. 1999 Feb-Apr;118(2-4):122-4. doi: 10.1159/000024046. Int Arch Allergy Immunol. 1999. PMID: 10224357 - Tolerance induction with CD4 monoclonal antibodies.
Waldmann H, Bemelman F, Cobbold S. Waldmann H, et al. Novartis Found Symp. 1998;215:146-52; discussion 152-8, 186-90. doi: 10.1002/9780470515525.ch11. Novartis Found Symp. 1998. PMID: 9760577 Review.
Cited by
- Advancement of antigen-specific immunotherapy: knowledge transfer between allergy and autoimmunity.
Richardson N, Wraith DC. Richardson N, et al. Immunother Adv. 2021 May 22;1(1):ltab009. doi: 10.1093/immadv/ltab009. eCollection 2021 Jan. Immunother Adv. 2021. PMID: 35919740 Free PMC article. Review. - The journey of SARS-CoV-2 in human hosts: a review of immune responses, immunosuppression, and their consequences.
Alshammary AF, Al-Sulaiman AM. Alshammary AF, et al. Virulence. 2021 Dec;12(1):1771-1794. doi: 10.1080/21505594.2021.1929800. Virulence. 2021. PMID: 34251989 Free PMC article. Review. - The Mechanism of Action of Antigen Processing Independent T Cell Epitopes Designed for Immunotherapy of Autoimmune Diseases.
Shepard ER, Wegner A, Hill EV, Burton BR, Aerts S, Schurgers E, Hoedemaekers B, Ng STH, Streeter HB, Jansson L, Wraith DC. Shepard ER, et al. Front Immunol. 2021 Apr 14;12:654201. doi: 10.3389/fimmu.2021.654201. eCollection 2021. Front Immunol. 2021. PMID: 33936079 Free PMC article. Review. - Mucosal Administration of E-selectin Limits Disability in Models of Multiple Sclerosis.
Quandt JA, Becquart P, Kamma E, Hallenbeck J. Quandt JA, et al. Front Mol Neurosci. 2019 Aug 27;12:190. doi: 10.3389/fnmol.2019.00190. eCollection 2019. Front Mol Neurosci. 2019. PMID: 31507371 Free PMC article. - T Cell Epitope Peptide Therapy for Allergic Diseases.
O'Hehir RE, Prickett SR, Rolland JM. O'Hehir RE, et al. Curr Allergy Asthma Rep. 2016 Feb;16(2):14. doi: 10.1007/s11882-015-0587-0. Curr Allergy Asthma Rep. 2016. PMID: 26768622 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials